Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
To compare safety of adjuvant OFS combined with anastrozole versus OFS combined with exemestane in Chinese premenopausal hormonal receptor(HR) positive breast cancer patients.
Epistemonikos ID: 56c3649c7aa91a933fd1fdb7a99e25bf090516f6
First added on: May 12, 2024